Document Detail

A model to describe myocardial drug disposition in the dog.
MedLine Citation:
PMID:  7391969     Owner:  NLM     Status:  MEDLINE    
A model, employing open-chested, anesthetized dogs, was developed to facilitate the study of myocardial drug disposition. Propranolol was employed as a model compound for initial investigation. Propranolol was administered as either a single i.v. bolus of 0.5 mg/kg or by a stepwise infusion protocol employing three rates: 2.6, 6.5 and 12.0 micrograms/kg/min. Blood and myocardial biopsy samples were obtained at specified times and the concentration of propranolol in tissue homogenates and plasma was determined by a high-pressure liquid chromotographic procedure. The concentration-time data obtained from the i.v. bolus studies were fitted to a three-compartment model where one of the compartments represented the myocardium. The model predicts that plasma and myocardial concentrations achieve distribution equilibrium within 2 min after administration. The myocardial-to-plasma concentration ratios ranged from 6.2 to 20.3 and were constant with time for each dog. The myocardial-to-plasma concentration ratios also remained constant during the infusion protocol, indicating linear accumulation up to myocardial concentrations of 6.7 micrograms/ml. To assess regional myocardial concentration differences, the concentration of drug in the right atrium was compared with the concentration of drug in the right atrium was compared with the concentration in the left ventricle at the end of the infusion protocol. The concentrations were not significantly different. The model developed will be used to study the myocardial disposition of several antiarrhythmic drugs and the factors which affect their rate and extent of accumulation.
R E Kates; P Jaillon
Related Documents :
15227259 - Prevention of ventricular fibrillation after aortic declamping during cardiac surgery.
8011559 - Effects of beta-blockers and ca(2+)-antagonists on the response of the isolated working...
2046029 - Effects of lidocaine on reperfusion arrhythmias and electrophysiological properties in ...
2568629 - Attenuation of ischaemia-induced regional myocardial acidosis by bevantolol, a beta 1-a...
7786689 - A prospective randomized trial of intravenous magnesium versus intravenous propranolol ...
835719 - Effects of intravenous anesthetic agents on left ventricular function in dogs.
6812979 - Cost-effectiveness of coronary artery bypass surgery.
3219209 - A case of thromboangiitis obliterans affecting coronary, pulmonary, and splenic vessels...
19365279 - Differences among low-molecular-weight heparins: evidence in patients with acute corona...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of pharmacology and experimental therapeutics     Volume:  214     ISSN:  0022-3565     ISO Abbreviation:  J. Pharmacol. Exp. Ther.     Publication Date:  1980 Jul 
Date Detail:
Created Date:  1980-09-26     Completed Date:  1980-09-26     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376362     Medline TA:  J Pharmacol Exp Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  31-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Injections, Intravenous
Models, Biological
Myocardium / metabolism*
Organ Size
Pharmaceutical Preparations / metabolism*
Propranolol / blood,  metabolism
Time Factors
Tissue Distribution
Reg. No./Substance:
0/Pharmaceutical Preparations; 525-66-6/Propranolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Anti-inflammatory and ulcerogenic effects and pharmacokinetics of dexamethasone in protein-deficient...
Next Document:  Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosome...